AIA, RIA, 100 tests

The presence of circulating anti-insulin antibodies in insulin treated diabetics is estimated on a semi-quantitative basis, by the determination of the binding of 125I-Tyr-A14-insulin to the serum fraction precipitated by the polyethylene glycol (PEG) (gamma globulins).

Catalog # KIP0091
Format RIA
Label I125
Size 100 tests
Sample Type Serum, Plasma
Sample Volume 100 µL
Controls 3 levels
Range 0-100 %
Sensitivity <8.2%
Incubation 2h at 37°C + 15min at RT
Shelf Life (weeks) 8

Due to local registration requirement, this product can not be sold in Canada – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: regulatory.affairs@diasource.be.

Documents - Download
Download "Instructions for Use" KIP0091.pdf
Download "Material Safety Data Sheet" MSKIP0091.pdf
Download catalogue "RIA" CATR.pdf
Download brochure "Auto-Immunity" BRAIM.pdf
Download RIA Availability Calendar CALRIA21d.pdf
Bridging Science And Diagnostics
Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.